Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gossamer Bio (GOSS) Interest & Investment Income (2022 - 2025)

Gossamer Bio's Interest & Investment Income history spans 4 years, with the latest figure at $447000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 160.08% year-over-year to $447000.0; the TTM value through Dec 2025 reached $2.0 million, up 10.74%, while the annual FY2025 figure was $2.0 million, 10.74% up from the prior year.
  • Interest & Investment Income reached $447000.0 in Q4 2025 per GOSS's latest filing, down from $687000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.7 million in Q2 2024 to a low of -$744000.0 in Q4 2024.
  • Average Interest & Investment Income over 4 years is $458062.5, with a median of $438500.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: surged 162.05% in 2023, then crashed 340.0% in 2024.
  • A 4-year view of Interest & Investment Income shows it stood at $594000.0 in 2022, then tumbled by 47.81% to $310000.0 in 2023, then plummeted by 340.0% to -$744000.0 in 2024, then soared by 160.08% to $447000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Interest & Investment Income are $447000.0 (Q4 2025), $687000.0 (Q3 2025), and $542000.0 (Q2 2025).